Â¥
5.19
Sep 13
New Key Statistics Module, Z-Score and F-Score
SZSE:300639 Key Ratios
Market Cap ¥ M | 3,355.34 |
Enterprise Value ¥ M | 2,615.06 |
P/E(ttm) | -- |
PE Ratio without NRI | 288.33 |
Forward PE Ratio | 19.24 |
Price/Book | 0.71 |
Price/Sales | 3.53 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 3.61 |
Revenue (TTM) ¥ M | 906.00 |
EPS (TTM) ¥ | -0.06 |
Beneish M-Score | -1.88 |
10-y EBITDA Growth Rate % | 29.20 |
5-y EBITDA Growth Rate % | 32.70 |
y-y EBITDA Growth Rate % | -124.40 |
EV-to-EBIT | -12.23 |
EV-to-EBITDA | -12.23 |
PEG | 8.82 |
Shares Outstanding M | 646.50 |
Net Margin (%) | -6.54 |
Operating Margin % | -17.27 |
Pre-tax Margin (%) | -23.96 |
Quick Ratio | 7.06 |
Current Ratio | 7.32 |
ROA % (ttm) | -1.02 |
ROE % (ttm) | -1.23 |
ROIC % (ttm) | -2.54 |
Dividend Yield % | 1.25 |
Altman Z-Score | 5.23 |
SZSE:300639 Number of Guru Trades
SZSE:300639 Volume of Guru Trades
Gurus Latest Trades with SZSE:300639
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300639 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangdong Hybribio Biotech Co Ltd Insider Transactions
No Available Data